Ownership
Private
Employees
~50
Therapeutic Areas
Psychiatry
Stage
Phase 1
Modalities
Small molecule

DemeRx General Information

Phase 1b trial ongoing for DMX-1001 (oral noribogaine) in alcohol use disorder. Previous studies showed positive results in opioid and cocaine dependence with ibogaine.

Contact Information

Website
Primary Industry
Biotech
Corporate Office
Miami, Florida
United States

Drug Pipeline

noribogaine
Phase 1
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to DemeRx's pipeline data

Book a demo

Key Partnerships

ATAI Life Sciences

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

DemeRx Funding

Deal TypeDateAmountStatusStage
Later Stage VCMay 8, 2015$289.6KCompletedPhase 1
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view DemeRx's complete valuation and funding history, request access »